SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-005654 to VTEX (VTEX) (CIK 0001793663) (VTEX)

VTEX (VTEX) (CIK 0001793663)
Date: May 30, 2023 · CIK: 0001793663 · Accession: 0000000000-23-005654

AI Filing Summary & Sentiment

File numbers found in text: 001-40626

Date
May 30, 2023
Author
Office of Technology
Form
UPLOAD
Company
VTEX (VTEX) (CIK 0001793663)

Letter

United States securities and exchange commission logo May 30, 2023 Ricardo Camatta Sodré Chief Financial Officer VTEX 125 Kingsway, WC2B 6NH London, United Kingdom Re:VTEX Form 20-F for the Year Ended December 31, 2022 Filed March 2, 2023 File No. 001-40626 Dear Ricardo Camatta Sodré: We have limited our review of your filing to the financial statements and related disclosures and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to these comments within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe our comments apply to your facts and circumstances, please tell us why in your response. After reviewing your response to these comments, we may have additional comments. Form 20-F for the Year Ended December 31, 2022 Item 5. Operating and Financial Review and Prospects Reconciliation of Non-GAAP Financial Measures FX Neutral measures, page 93 1.We note that your presentation of most of the income statement line items on an FX neutral basis for all periods presented is inconsistent with the guidance set forth in Question 102.10(c) of the C&DI on Non-GAAP Financial Measures. In future filings, please limit your presentation to certain key non-GAAP metrics on an FX neutral basis. 2.Refer to Item 10(e)(1)(i)(B) of Regulation S-K. In future filings, in connection with your reconciliation of certain non-GAAP metrics on an FX Neutral basis to their most comparable GAAP measures, please disclose the ranges of average monthly exchange rates for all periods presented, including each respective inflation adjustment in countries with hyper-inflation, that were used to apply to the IFRS amounts in order to calculate

FirstName LastNameRicardo Camatta Sodré Comapany NameVTEX May 30, 2023 Page 2 FirstName LastName Ricardo Camatta Sodré VTEX May 30, 2023 Page 2 what your results would have been had exchange rates remained stable from one year to the next. In this regard, we note your disclosure on page 6. Notes to the Consolidated Financial Statements 2.3 Segment reporting a. Segment revenue by region, page F-13 3.If material, please separately disclose revenues from external customers attributed to an individual foreign country and your basis for revenue attribution. Refer to paragraph 33 of IFRS 8. In closing, we remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. You may contact Kathryn Jacobson, Senior Staff Accountant at (202) 551-3365 or Robert Littlepage, Accountant Branch Chief at (202) 551-3361 with any questions. Sincerely, Division of Corporation Finance Office of Technology

Show Raw Text
United States securities and exchange commission logo
May 30, 2023
Ricardo Camatta Sodré
Chief Financial Officer
VTEX
125 Kingsway, WC2B 6NH
London, United Kingdom
Re:VTEX
Form 20-F for the Year Ended December 31, 2022
Filed March 2, 2023
File No. 001-40626
Dear Ricardo Camatta Sodré:
            We have limited our review of your filing to the financial statements and related
disclosures and have the following comments.  In some of our comments, we may ask you to
provide us with information so we may better understand your disclosure.
            Please respond to these comments within ten business days by providing the requested
information or advise us as soon as possible when you will respond.  If you do not believe our
comments apply to your facts and circumstances, please tell us why in your response.
            After reviewing your response to these comments, we may have additional comments.
Form 20-F for the Year Ended December 31, 2022
Item 5. Operating and Financial Review and Prospects
Reconciliation of Non-GAAP Financial Measures
FX Neutral measures, page 93
1.We note that your presentation of most of the income statement line items on an FX
neutral basis for all periods presented is inconsistent with the guidance set forth in
Question 102.10(c) of the C&DI on Non-GAAP Financial Measures.  In future filings,
please limit your presentation to certain key non-GAAP metrics on an FX neutral basis.
2.Refer to Item 10(e)(1)(i)(B) of Regulation S-K.  In future filings, in connection with your
reconciliation of certain non-GAAP metrics on an FX Neutral basis to their most
comparable GAAP measures, please disclose the ranges of average monthly exchange
rates for all periods presented, including each respective inflation adjustment in countries
with hyper-inflation, that were used to apply to the IFRS amounts in order to calculate

 FirstName LastNameRicardo Camatta Sodré
 Comapany NameVTEX
 May 30, 2023 Page 2
 FirstName LastName
Ricardo Camatta Sodré
VTEX
May 30, 2023
Page 2
what your results would have been had exchange rates remained stable from one year to
the next.  In this regard, we note your disclosure on page 6.
Notes to the Consolidated Financial Statements
2.3 Segment reporting
a. Segment revenue by region, page F-13
3.If material, please separately disclose revenues from external customers attributed to an
individual foreign country and your basis for revenue attribution.  Refer to paragraph 33
of IFRS 8.
            In closing, we remind you that the company and its management are responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or
absence of action by the staff.
            You may contact Kathryn Jacobson, Senior Staff Accountant at (202) 551-3365 or Robert
Littlepage, Accountant Branch Chief at (202) 551-3361 with any questions.
Sincerely,
Division of Corporation Finance
Office of Technology